Durability of treatment response to zolpidem using a partial reinforcement regimen: does this strategy require priming?
Sign Up to like & getrecommendations! Published in 2021 at "Sleep medicine"
DOI: 10.1016/j.sleep.2021.04.041
Abstract: BACKGROUND Previous research has shown that after one month of full dose nightly treatment with zolpidem (priming), subjects with chronic insomnia (CI) switched to intermittent dosing with medication and placebos were able to maintain their… read more here.
Keywords: zolpidem; treatment response; treatment; partial reinforcement ... See more keywords
Intermittent Dosing of Dabrafenib and Trametinib in Metastatic BRAFV600E Mutated Papillary Thyroid Cancer: Two Case Reports
Sign Up to like & getrecommendations! Published in 2017 at "Thyroid"
DOI: 10.1089/thy.2017.0106
Abstract: Background: A multi-institutional, randomized phase II trial of continuous dosing of dabrafenib with or without trametinib is ongoing in metastatic thyroid cancer. Preclinical evidence and emerging clinical experience in other cancers support evaluating intermittent dosing… read more here.
Keywords: mutated papillary; papillary thyroid; thyroid cancer; intermittent dosing ... See more keywords
Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B
Sign Up to like & getrecommendations! Published in 2020 at "Medical Mycology"
DOI: 10.1093/mmy/myz134
Abstract: Abstract Triazole resistant A. fumigatus has been documented in many parts of the world. In the Netherlands, incidence is now above 10% and results in the need for long-term parenteral therapy with liposomal amphotericin B… read more here.
Keywords: therapy opat; antifungal therapy; treatment; liposomal amphotericin ... See more keywords